FGF23 effects on the heart—levels, time, source, and context matter

Academic Article


  • Fibroblast growth factor 23 (FGF23) has appeared as a hormone that is massively elevated in patients with chronic kidney disease. Whether FGF23 is a risk factor that associates with cardiac pathologies and cardiovascular mortality, as suggested by a variety of clinical studies, or additionally acts as a causative factor that induces cardiac injury, as more recently indicated by cell culture and animal studies, is under debate and the center of many ongoing experimental studies.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Faul C
  • Start Page

  • 7
  • End Page

  • 11
  • Volume

  • 94
  • Issue

  • 1